Health Robotics reportedly announced that apropos to the official declaration of its strategic partnership with McKesson for CytoCare robots only, all of its 13 North American customers have provided 100 percent rock solid support and encouraging testimonials to back its all round professionalism and product reliability.

“CytoCare is a complex and revolutionary technology that requires highly-skilled engineers and a sizeable service commitment, which is why we are very pleased to have partnered with a world class service and engineering organization such as McKesson Automation," said Werner Rainer, chief executive officer for Health Robotics.

"We have seen McKesson's announcement that it has become the exclusive North American strategic partner for Health Robotics' CytoCare, an Oncology I.V. Admixtures Robot implemented at our hospital in early 2008,” said Nancy Stolpman, director of pharmacy for the University of Colorado Hospital. “We went "live" about a year ago and have since utilized CytoCare to prepare patient doses from as many as 60 different drug vials of antibiotic, chemotherapy, and, or monoclonal antibody therapies. The University of Colorado Hospital is a long-standing customer of McKesson Corporation, and looks forward to extending our relationship ever farther."

Officials claim that McKesson is well respected and trusted organization with significant presence in North America and a fair number of hospitals are planning to take delivery of i.v.STATION in the next few months and definitely before year ending.

"We have been following the recent developments in I.V. robotics by multiple start-up companies and have evaluated alternative technologies at both Duke University Hospital and Duke Children's Hospital and Health Center,” said Paul Bush, chief pharmacy officer for Duke University Hospital and Duke Children's Hospital and Health Center. “We noticed that all of these start-up companies have ideas with merit, but thought their service infrastructure in North America should be more fully developed.

 “Given the fact that Health Robotics' HL7 interface technology is identical for both CytoCare and i.v.STATION, we are very pleased to see the announcement of the McKesson-Health Robotics strategic partnership and are confident that it will only make our i.v.STATION HL7 interface efforts smoother,” said Bush. “In addition, it is very reassuring to see such a mature and omnipresent service organization like McKesson Corporation endorse Health Robotics' technology. We look forward to expand our relationship with McKesson Corporation.”

Collaborative efforts, such as this one between Health Robotics and McKesson, are in keeping with one of the seven mantras of the time, which dictates that organizations must make serious efforts to reach out and work with each other. The seven guidelines for succeeding in current economic environment are collectively called the CES (News - Alert) 7 and were pronounced and initiated at the Consumer Electronics Show 2009.

“The McKesson-Health Robotics strategic partnership announcement is a great match-up, and definitely puts to bed any support or service concerns we had in the past," said Thomas Crampton, director of pharmacy.